These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 10741724)
1. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724 [TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53. Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253 [TBL] [Abstract][Full Text] [Related]
3. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes. Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111 [TBL] [Abstract][Full Text] [Related]
4. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells. Tokunaga N; Murakami T; Endo Y; Nishizaki M; Kagawa S; Tanaka N; Fujiwara T Clin Cancer Res; 2005 Feb; 11(3):1312-8. PubMed ID: 15709203 [TBL] [Abstract][Full Text] [Related]
5. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. Gomi S; Nakao M; Niiya F; Imamura Y; Kawano K; Nishizaka S; Hayashi A; Sobao Y; Oizumi K; Itoh K J Immunol; 1999 Nov; 163(9):4994-5004. PubMed ID: 10528204 [TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824 [TBL] [Abstract][Full Text] [Related]
7. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner. Kontani K; Teramoto K; Ozaki Y; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Yokomise H; Ohkubo I Int J Oncol; 2004 Dec; 25(6):1537-42. PubMed ID: 15547688 [TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck. Ito D; Visus C; Hoffmann TK; Balz V; Bier H; Appella E; Whiteside TL; Ferris RL; DeLeo AB Int J Cancer; 2007 Jun; 120(12):2618-24. PubMed ID: 17294448 [TBL] [Abstract][Full Text] [Related]
9. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma. Takahashi T; Irie RF; Nishinaka Y; Hoon DS Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820 [TBL] [Abstract][Full Text] [Related]
10. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma. Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056 [TBL] [Abstract][Full Text] [Related]
11. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028 [TBL] [Abstract][Full Text] [Related]
12. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610 [TBL] [Abstract][Full Text] [Related]
13. p53 as an immunotherapeutic target in head and neck cancer. Hoffmann TK; Bier H; Donnenberg AD; Whiteside TL; De Leo AB Adv Otorhinolaryngol; 2005; 62():151-60. PubMed ID: 15608425 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Nikitina EY; Clark JI; Van Beynen J; Chada S; Virmani AK; Carbone DP; Gabrilovich DI Clin Cancer Res; 2001 Jan; 7(1):127-35. PubMed ID: 11205900 [TBL] [Abstract][Full Text] [Related]
15. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387 [TBL] [Abstract][Full Text] [Related]
16. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999 [TBL] [Abstract][Full Text] [Related]
17. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients. Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265 [TBL] [Abstract][Full Text] [Related]
19. The use of transgenic mice to generate high affinity p53 specific cytolytic T cells. Yu Z; Liu X; McCarty TM; Diamond DJ; Ellenhorn JD J Surg Res; 1997 May; 69(2):337-43. PubMed ID: 9224403 [TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Komori H; Nakatsura T; Senju S; Yoshitake Y; Motomura Y; Ikuta Y; Fukuma D; Yokomine K; Harao M; Beppu T; Matsui M; Torigoe T; Sato N; Baba H; Nishimura Y Clin Cancer Res; 2006 May; 12(9):2689-97. PubMed ID: 16675560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]